200 - 3650 GILMORE WAY, BURNABY, A1
Market cap: $3.4B (12/18/2025)
Price: $44.10
Xenon Pharmaceuticals Increases Share Reserve in 2025 Inducement Plan
Reports Third Quarter 2025 Financial Results & Business Update
Amended material disclosure
Announces Appointment of Tucker Kelly as Chief Financial Officer
Reports Second Quarter 2025 Financial Results & Business Update
Changes in Board, Management or Compensation
News
Financial Results, Reg. FD
Q3
Q2
Q1
FY 2024
FY 2023
Registration Statement for Securities to be Offered to Employees
S-3ASR
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Free Writing Prospectus
Confidential Treatment Order
Correspondence
Submission Upload